Please assess the completion status of the following clinical trial:

Trial Title: SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of asthma \< 3 months~* Prescribed daily use of glucocorticosteroids for at least 3 months prior to Visit 1~Exclusion Criteria:~* Smoking history \> 10 pack-years~* Asthma exacerbation requiring change in asthma treatment during the last 14 days prior to inclusion~* Any significant disease or disorder that my jeopardize the safety of the patient.~Additional inclusion and exclusion criteria will be evaluated by the investigator.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).